Rick Doblin & Dr. Torsten Passie: The Future of MDMA-assisted psychotherapy скачать в хорошем качестве

Rick Doblin & Dr. Torsten Passie: The Future of MDMA-assisted psychotherapy

Rick Doblin is coming ever closer to his dream of making MDMA an FDA-approved medicine, now that the FDA has designated MDMA-assisted psychotherapy for PTSD a Breakthrough Therapy. We're thrilled to have him as speaker in April at ICPR2020: https://icpr2020.net/speakers/rick-do... This Q&A session was part of the Opening Up symposium in Amsterdam, May 7th 2019. Joost Breeksema (director of OPEN Foundation) interviews Rick Doblin, PhD (founder, executive director of MAPS) & Torsten Passie, MD (psychiatrist and author of "The Science of Microdosing Psychedelics") about the therapeutic potential of MDMA, the differences with classical psychedelics, therapeutic interventions, and the various ways in which these therapies could be integrated into mainstream health care. Rick Doblin, Torsten Passie, and many others will be among the speakers at the upcoming Interdisciplinary Conference on Psychedelic Research! Full list of speakers, ticket prices, and more information available on http://icpr2020.net/